Abstract:Influenza B virus is one of the causes for seasonal influenza,which can account for serious illness or even death in some cases.We tested the expression of extracellular domain of hemagglutinin (HA-ecto) of influenza B viruses in mammalian cells,and then determined the immunogenicity of HA-ecto in mice.The gene sequence encoding influenza B virus HA-ecto,foldon sequence,and HIS tag was optimized and inserted into pCAGGS vector.The opening reading frame (ORF) of neuraminidase was also cloned into pCAGGS.The pCAGGS-HA-ecto and pCAGGS-NA were co-transfected into 293T cells using linear polyethylenimine.Cell supernatant after transfection was collected after 96 h,and the secreted trimmeric HA-ecto protein was purified by nickel ion affinity chromatography and size exclusion chromatography.Subsequently,the mice were immunized with HA-ecto protein,and the corresponding antibody titers were detected by ELISA and hemagglutination inhibition (HAI) assays.The results showed that soluble trimeric HA-ecto protein could be obtained using mammalian cell expression system.Moreover,trimeric HA-ecto protein,in combination with the adjuvant,induced high levels of ELISA and HAI antibodies against homogenous and heterologous antigens in mice.Thus,the soluble HA-ecto protein expressed in mammalian cells could be used as a recombinant subunit vaccine candidate for influenza B virus.